AzTrials
AzTrials

Pathological Use of Internet GamesStimNETNCT04120714

Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming

A study testing Active tDCS and Questionnaires in people with Pathological Use of Internet Games, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Internet has grown considerably in the last twenty years, and as a result, cases of excessive iinterney use have emerged. These cases, which have clinical similarities with substance addiction, involve the various activities related to the Internet (online gambling, discussion forums, online networking, e-mail… Read more about this study

Who is it for?
Ages 12 years and older
Conditions the study is for
Pathological Use of Internet Games
What is being tested?
Active tDCS and Questionnaires
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteFrance
Study dates
6 Jan 2020to Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patient aged ≥ 12 years old
  • Patient and/or parents who have given oral consent
  • Patient with PUIG (DSM-5 criteria)
  • Patient that is motivated and willing to reduce or stop internet gaming

Who cannot join

  • a person who is not affiliated to or not a beneficiary of a social security scheme
  • Patient with severe chronic psychiatric comorbidity (schizophrenia, paranoia, chronic hallucinatory psychosis) and bipolar disorder types I and II
  • Patient with a gambling addiction
  • Patient who has had a recent change (< 1 month) in the prescription of psychotropic treatment
  • Patient with an addiction to a psychoactive substance other than tobacco
  • Patient receiving psychiatric care without consent or legal protection (guardianship, curatorship)
Show all 11Show fewer
  • Minor patient without parental consent for care
  • Patient with severe heart, kidney, liver or lung failure
  • Patient with a contraindication to the practice of tDCS: metal parts, medical devices implanted in the brain
  • Pregnancy or breastfeeding in progress (negative pregnancy test)
  • Patient unable to commit to a three-month follow-up

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU de DIJON

    Dijon, 21079

    Benoît TROJAK, 3 80 29 37 69 ext. +33, benoit.trojak@chu-dijon.fr

    Benoît TROJAK

    Recruiting

Other trials in France

About this study

Official title: Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming : Randomized, Controlled, Double-blind, Monocentric Pilot Study

The Internet has grown considerably in the last twenty years, and as a result, cases of excessive iinterney use have emerged. These cases, which have clinical similarities with substance addiction, involve the various activities related to the Internet (online gambling, discussion forums, online networking, e-mail, pornography, shopping, etc.). However, to date, only the pathological use of Internet gaming (PUIG) is referenced in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5, section III).

In PUIG, an individual loses control when gambling online. He/she typically spends 8 to 10 hours on this activity, sometimes without eating or sleeping. Usual obligations, such as school or work, or family obligations are neglected. PUIG can cause great psychological and social suffering. Neurological complications (epilepsy) and deaths (cardiac arrest) related to PUIG have also been reported. These situations are all the more dramatic because they often affect adolescents and young adults. In Asia, PUIG has become a public health problem. To date, no treatment has been validated for this disorder.

Non-invasive brain stimulation (NIBS) techniques can modulate neural activity in the dorsolateral prefrontal cortex (DLPFC). This modulation makes it possible to reduce addictive behaviours through different mechanisms (reduction of craving, impulsivity, and decision-making disorders). These techniques could be effective for PUIG.

Being tested
Active tDCS, Placebo tDCS, Questionnaires

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active tDCSDevice

    active D.C. transcranial stimulation (delivers a low current (1 to 2 mA)) for 10 to 30 minutes, during 5 sessions

  • Placebo tDCSDevice

    inactive DC transcranial stimulation (delivering a non-significant current at the beginning and end of the stimulation, simulating active stimulation) for 10 to 30 minutes, during 5 sessions

  • QuestionnairesOther

    • visual analogue scale (VAS)
    • impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)
    • Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)
    • Go-No go test
    • HAM-D scale
    • SF-12 quality of life scale
Study groups in NCT04120714
Study groupRoleWhat they receive
Active tDCS groupExperimentalActive tDCS
Receives: Device: Active tDCS; Other: Questionnaires
Placebo tDCS groupPlacebo comparatorInactive tDCS
Receives: Device: Placebo tDCS; Other: Questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evolution of scores on the IAT scale (Internet Addiction Test)

    Evolution of scores on the IAT (Internet Addiction Test) scale 4 weeks after treatment with tDCS (5 sessions) compared to the 4 weeks preceding brain stimulation

    Measured: 4 weeks after tDCS treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2019
  2. Study start6 Jan 2020
  3. Primary completionNov 2027 (estimated)
  4. Study completionNov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04120714
Sponsor's protocol ID
TROJAK 2019
Acronym
StimNET
Status last verified
Apr 2026
First submitted
8 Oct 2019
Last updated
13 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Active tDCS and Questionnaires in people with Pathological Use of Internet Games, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Benoît TROJAK (03.80.29.37.69 ext. +33, benoit.trojak@chu-dijon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evolution of scores on the IAT scale (Internet Addiction Test) (time frame: 4 weeks after tDCS treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in